Tarsus Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 171.97M178.91M227.86M265.49M376.99M
Current Assets
Cash & Equivalents 168.13M171.33M71.66M224.95M94.82M
Short-term Investments 0.02M0.48M145.37M2.50M196.56M
Cash & Current Investments 168.15M171.81M217.03M227.44M291.38M
Receivables - Net 16.62M46.76M
Receivables - Other 0.02M0.20M3.58M1.09M1.30M
Receivables 17.71M48.06M
Raw Materials 2.53M
Work In Process 0.39M0.61M
Finished Goods 0.18M2.01M
Inventory 3.11M2.62M
Prepaid Assets 2.49M4.04M4.77M7.87M14.65M
Current Assets 170.66M175.95M225.38M256.13M356.70M
Non-Current Assets
Property, Plant & Equipment (Net) 0.55M0.76M0.96M1.47M2.31M
Long-Term Investments 0.37M0.63M3.00M
Intangibles 3.87M8.33M
Goodwill & Intangibles 3.87M8.33M
Other Non-Current Assets 0.08M1.13M0.58M1.51M2.56M
Non-Current Assets 1.32M2.96M2.49M9.36M20.29M
Liabilities
Current Liabilities
Accounts Payables 4.35M8.68M9.91M23.69M64.79M
Payables 4.35M8.68M9.91M23.69M64.79M
Accumulated Expenses 1.04M2.80M5.52M13.24M15.82M
Total Current Liabilities 5.39M11.48M15.43M36.94M80.61M
Non-Current Liabilities
Non-Current Debt 19.43M29.82M71.84M
Other Non-Current Liabilities 0.60M0.70M0.10M1.75M
Total Non-Current Liabilities 5.39M11.48M34.86M66.75M
Liabilities
Total Liabilities 5.99M12.18M34.96M68.50M152.46M
Shareholder's Equity
Total Debt 19.43M29.82M71.84M
Common Equity 165.98M166.73M192.90M196.99M224.53M
Shareholder's Equity 165.98M166.73M192.90M196.99M224.53M
Liabilities and Shareholders Equity 171.97M178.91M227.86M265.49M376.99M
Retained Earnings -32.84M-46.67M-108.76M-244.66M-360.21M
Treasury Shares 0.02M0.55M1.71M1.92M